Professor Tim Child joins Apricity Fertility as Chief Medical Officer

Apricity Fertility has announced the appointment of Professor Tim Child as the company’s Chief Medical Officer, bringing with him over two decades of expertise in reproductive medicine and IVF advancements. 

As an Associate Professor of Reproductive Medicine at the Nuffield Department of Women’s and Reproductive Health, University of Oxford, and a Board Member of the Human Fertilisation and Embryology Authority (HFEA), Professor Child is a highly respected leader in the field of fertility care.

His commitment to advancing scientific understanding and improving clinical outcomes has led to numerous innovations in IVF and reproductive health.

Professor Tim Child shared his excitement about joining Apricity:

“I am thrilled to be joining Apricity as Chief Medical Officer and to be part of a team that is truly committed to innovation in fertility care.

“My mission has always been to advance the scientific understanding of reproductive medicine and to provide the highest standards of care for patients.

“Apricity’s digital-first approach is revolutionising how we deliver fertility care, and I am excited to contribute to the company’s growth and the future of IVF and fertility treatment.”

With 20+ years of teaching and research at the University of Oxford, Professor Child has been a pivotal figure in reproductive medicine.

He has contributed to multiple publications and research studies, driving significant advancements in IVF treatment protocols.

His work has been recognised with prestigious accolades, including a Lifetime Achievement Award from the European Fertility Society in 2021.

Prior to joining Apricity, Professor Child held several esteemed positions, including Medical Director of Oxford Fertility and Founding Director and Group Medical Director of The Fertility Partnership, one of the largest providers of assisted conception treatments in Europe.

His leadership at TFP established it as a centre of excellence for fertility care, setting high standards for quality and patient care across Europe.

Professor Child is also the Chair of Trustees at The Fertility Alliance Charity and continues his role as Chair of the Scientific and Clinical Advances Advisory Committee (SCAAC) within the HFEA, where he plays a critical role in shaping the future of fertility treatments in the UK.

At Apricity, Professor Child will spearhead the company’s clinical strategy, focusing on the development and integration of cutting-edge fertility treatments that align with Apricity’s commitment to personalised, patient-centric care.

He will also be responsible for driving research initiatives aimed at improving fertility outcomes and shaping the future of fertility care through innovative technology and science.

Professor Child’s appointment marks a significant step forward in Apricity’s mission to transform fertility care through innovation, digital health, and personalised patient experience.

His deep clinical expertise, combined with a passion for patient well-being, makes him the perfect leader to guide Apricity into the next phase of its growth.

For more updates, follow Professor Tim Child on Instagram at @drtimchild, where he hosts a weekly Instagram Live, answering Live Q&As with other experts in the field and also shares his insights on fertility care, reproductive health, and advancements in IVF treatments.